Literature DB >> 32569866

Harnessing carbon monoxide-releasing platforms for cancer therapy.

Yang Zhou1, Wenqi Yu1, Jun Cao2, Huile Gao3.   

Abstract

Carbon monoxide (CO) is a gaseous molecule that has drawn growing concerns for cancer treatment, due to its multifaceted regulation of cellular function and the tumor microenvironment. The past decades have witnessed extensive efforts into this emerging field, centered in the development of intelligent CO donors and CO delivery based on nanomaterials. However, CO delivery is beset with biosafety problems arising from burst release and the demand for high therapeutic concentrations in tumor tissues. In this review, we provide an overview of physiological and therapeutic effects of CO, and discuss the recent progress in CO application for cancer treatment. The main emphasis is placed on CO-releasing platforms to overcome the challenges in delivery and underlying synergistic mechanism against cancer. Eventually, the obstacles confronted and future directions of CO therapy are also highlighted for future clinical translation.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer therapy; Carbon monoxide; Delivery strategies; Nanomaterials

Mesh:

Substances:

Year:  2020        PMID: 32569866     DOI: 10.1016/j.biomaterials.2020.120193

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  4 in total

1.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

2.  Development of Triggerable, Trackable, and Targetable Carbon Monoxide Releasing Molecules.

Authors:  Livia S Lazarus; Abby D Benninghoff; Lisa M Berreau
Journal:  Acc Chem Res       Date:  2020-09-15       Impact factor: 22.384

Review 3.  Engineered extracellular vesicles: potentials in cancer combination therapy.

Authors:  Jiangbin Chen; Qi Tan; Zimo Yang; Yang Jin
Journal:  J Nanobiotechnology       Date:  2022-03-15       Impact factor: 10.435

4.  Liposomal Artificial Red Blood Cell-Based Carbon Monoxide Donor Is a Potent Renoprotectant against Cisplatin-Induced Acute Kidney Injury.

Authors:  Kazuaki Taguchi; Yuto Suzuki; Moeko Tsutsuura; Kana Hiraoka; Yuki Watabe; Yuki Enoki; Masaki Otagiri; Hiromi Sakai; Kazuaki Matsumoto
Journal:  Pharmaceutics       Date:  2021-12-27       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.